Wordt geladen...
A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time
Dabigatran is an oral anticoagulant that is increasingly used for atrial fibrillation (AF). Presently, many authorities state that routine laboratory coagulation monitoring is not required. However, data have recently been published demonstrating that higher trough plasma dabigatran concentrations a...
Bewaard in:
| Gepubliceerd in: | Br J Clin Pharmacol |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BlackWell Publishing Ltd
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4243910/ https://ncbi.nlm.nih.gov/pubmed/24592851 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12364 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|